Attached files
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
In
connection with this Annual Report of MusclePharm Corporation (the
“Company”), on Form 10-K for the year ended December
31, 2017, as filed with the U.S. Securities and Exchange Commission
on the date hereof (the “Report”), I, Ryan Drexler,
Principal Financial Officer of the Company, certify pursuant to 18
U.S.C. Section. 1350, as adopted pursuant to Section. 906 of the
Sarbanes-Oxley Act of 2002, that to the best of my
knowledge:
|
(1)
|
The
Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934, as amended;
and
|
|
(2)
|
The
information contained in the Report, fairly presents, in all
material respects, the financial condition and results of
operations of the Company.
|
|
|
|
|
Date: April 2, 2018
|
|
By:
|
/s/ Ryan Drexler
|
|
|
|
Ryan Drexler
|
|
|
|
Chief Executive Officer and President
|
|
|
|
(Principal Financial Officer)
|